These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 11477542)
21. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. Gran B; Zhang GX; Yu S; Li J; Chen XH; Ventura ES; Kamoun M; Rostami A J Immunol; 2002 Dec; 169(12):7104-10. PubMed ID: 12471147 [TBL] [Abstract][Full Text] [Related]
22. Action of treosulfan in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis and human lymphocytes. Weissert R; Wiendl H; Pfrommer H; Storch MK; Schreiner B; Barth S; Seifert T; Melms A; Dichgans J; Weller M J Neuroimmunol; 2003 Nov; 144(1-2):28-37. PubMed ID: 14597095 [TBL] [Abstract][Full Text] [Related]
23. Induction of EAE in mice with recombinant human MOG, and treatment of EAE with a MOG peptide. Devaux B; Enderlin F; Wallner B; Smilek DE J Neuroimmunol; 1997 May; 75(1-2):169-73. PubMed ID: 9143251 [TBL] [Abstract][Full Text] [Related]
24. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Lyons JA; San M; Happ MP; Cross AH Eur J Immunol; 1999 Nov; 29(11):3432-9. PubMed ID: 10556797 [TBL] [Abstract][Full Text] [Related]
25. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE. Mony JT; Khorooshi R; Owens T Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747 [TBL] [Abstract][Full Text] [Related]
26. Enhancement of Th2 response in IL-6-deficient mice immunized with myelin oligodendrocyte glycoprotein. Okuda Y; Sakoda S; Saeki Y; Kishimoto T; Yanagihara T J Neuroimmunol; 2000 Jun; 105(2):120-3. PubMed ID: 10742553 [TBL] [Abstract][Full Text] [Related]
27. Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis. Chang TT; Jabs C; Sobel RA; Kuchroo VK; Sharpe AH J Exp Med; 1999 Sep; 190(5):733-40. PubMed ID: 10477557 [TBL] [Abstract][Full Text] [Related]
28. IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Serada S; Fujimoto M; Mihara M; Koike N; Ohsugi Y; Nomura S; Yoshida H; Nishikawa T; Terabe F; Ohkawara T; Takahashi T; Ripley B; Kimura A; Kishimoto T; Naka T Proc Natl Acad Sci U S A; 2008 Jul; 105(26):9041-6. PubMed ID: 18577591 [TBL] [Abstract][Full Text] [Related]
31. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. Weissert R; de Graaf KL; Storch MK; Barth S; Linington C; Lassmann H; Olsson T J Immunol; 2001 Jun; 166(12):7588-99. PubMed ID: 11390515 [TBL] [Abstract][Full Text] [Related]
32. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice. Hu X; Qin X Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227 [TBL] [Abstract][Full Text] [Related]
33. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis. Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934 [TBL] [Abstract][Full Text] [Related]
34. Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation. Haroon F; Drögemüller K; Händel U; Brunn A; Reinhold D; Nishanth G; Mueller W; Trautwein C; Ernst M; Deckert M; Schlüter D J Immunol; 2011 Jun; 186(11):6521-31. PubMed ID: 21515788 [TBL] [Abstract][Full Text] [Related]
35. IL-5-deficient mice are susceptible to experimental autoimmune encephalomyelitis. Weir C; Bernard CC; Bäckström BT Int Immunol; 2003 Nov; 15(11):1283-9. PubMed ID: 14565926 [TBL] [Abstract][Full Text] [Related]
36. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Lyons JA; Ramsbottom MJ; Cross AH Eur J Immunol; 2002 Jul; 32(7):1905-13. PubMed ID: 12115610 [TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis. Buhler LA; Samara R; Guzman E; Wilson CL; Krizanac-Bengez L; Janigro D; Ethell DW BMC Neurosci; 2009 Mar; 10():17. PubMed ID: 19267908 [TBL] [Abstract][Full Text] [Related]
38. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Mendel I; Kerlero de Rosbo N; Ben-Nun A Eur J Immunol; 1995 Jul; 25(7):1951-9. PubMed ID: 7621871 [TBL] [Abstract][Full Text] [Related]
39. Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity. Slavin AJ; Soos JM; Stuve O; Patarroyo JC; Weiner HL; Fontana A; Bikoff EK; Zamvil SS J Clin Invest; 2001 Oct; 108(8):1133-9. PubMed ID: 11602620 [TBL] [Abstract][Full Text] [Related]
40. Abnormal T cell activation caused by the imbalance of the IL-1/IL-1R antagonist system is responsible for the development of experimental autoimmune encephalomyelitis. Matsuki T; Nakae S; Sudo K; Horai R; Iwakura Y Int Immunol; 2006 Feb; 18(2):399-407. PubMed ID: 16415102 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]